• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芋螺毒素包封壳聚糖纳米粒的制备及其皮肤渗透性评价。

Preparation of Conotoxin-Encapsulated Chitosan Nanoparticles and Evaluation of Their Skin Permeability.

作者信息

Li Haigang, Yao JiPeng, Guo Yong, Huo JingJing, Zhang Haijuan, Zhang Zengtao, Zhao Jinlong, Zhang Chun

机构信息

College of Medicine, Linyi University, Linyi, 276000, Shandong, People's Republic of China.

Shandong Renrui Biotechnology Inc., RiZhao, Shandong, People's Republic of China.

出版信息

AAPS PharmSciTech. 2023 Jan 27;24(1):53. doi: 10.1208/s12249-023-02509-8.

DOI:10.1208/s12249-023-02509-8
PMID:36707459
Abstract

μ-Conotoxin CnIIIC (conotoxin, CTX)-loaded chitosan nanoparticles (CTX-NPs) were prepared using the ionic cross-linking method. The CTX-NPs were spherical and well with a polydispersity index of 0.292 ± 0.039, drug loading efficiency of 25.9 ± 1.2%, and encapsulation efficiency of 95.6 ± 1.3%. In vitro release studies showed that the release behavior of CTX-NPs in a pH 5.0 acetate buffer followed zero-order kinetics. In vitro transdermal experiments using Franz diffusion cells mounted with mouse abdominal skin demonstrated that the cumulative intradermal deposition amount of CTX per unit area in 8 h (D) and permeability coefficient (P) of CTX loaded on CTX-NPs were 2.30- and 7.71-times that of the CTX solution. In vivo transdermal experiments in mice showed that the amount of CTX deposited in the skin after 8 h of CTX saline administration was significantly lower than that of CTX deposited in the skin after administration of CTX-NPs. In vitro fluorescence labeling transdermal studies through Franz diffusion cells mounted with mouse abdominal skin indicated that CTX-NPs aggregated at hair follicles. Skin irritation tests in mice indicated that the irritation due to CTX-NPs was negligible. The cytotoxicity experiment showed that the viability of Balb/c 3T3 cells with CTX-NPs containing 230 μg/mL (0.08 μM) CTX was greater than 75%. CTX-NPs increase intradermal deposition of CTX by accumulating in hair follicles, which has positive implications for transdermal penetration of CTX.

摘要

采用离子交联法制备了负载μ-芋螺毒素CnIIIC(芋螺毒素,CTX)的壳聚糖纳米粒(CTX-NPs)。CTX-NPs呈球形,分散性良好,多分散指数为0.292±0.039,载药效率为25.9±1.2%,包封率为95.6±1.3%。体外释放研究表明,CTX-NPs在pH 5.0的醋酸盐缓冲液中的释放行为符合零级动力学。使用装有小鼠腹部皮肤的Franz扩散池进行的体外透皮实验表明,CTX-NPs负载的CTX在8小时内每单位面积的皮内累积沉积量(D)和渗透系数(P)分别是CTX溶液的2.30倍和7.71倍。小鼠体内透皮实验表明,CTX生理盐水给药8小时后皮肤中CTX的沉积量显著低于CTX-NPs给药后皮肤中CTX的沉积量。通过装有小鼠腹部皮肤的Franz扩散池进行的体外荧光标记透皮研究表明,CTX-NPs在毛囊处聚集。小鼠皮肤刺激性试验表明,CTX-NPs引起的刺激可忽略不计。细胞毒性实验表明,含有230μg/mL(0.08μM)CTX的CTX-NPs对Balb/c 3T3细胞的活力大于75%。CTX-NPs通过在毛囊中积累增加了CTX的皮内沉积,这对CTX的透皮渗透具有积极意义。

相似文献

1
Preparation of Conotoxin-Encapsulated Chitosan Nanoparticles and Evaluation of Their Skin Permeability.芋螺毒素包封壳聚糖纳米粒的制备及其皮肤渗透性评价。
AAPS PharmSciTech. 2023 Jan 27;24(1):53. doi: 10.1208/s12249-023-02509-8.
2
and evaluation of chitosan gel containing metformin-loaded polymeric nanoparticles for topical treatment of melanoma.并评估壳聚糖凝胶载有二甲双胍的聚合物纳米粒用于黑素瘤的局部治疗。
Drug Dev Ind Pharm. 2024 Jul;50(7):593-604. doi: 10.1080/03639045.2024.2372290. Epub 2024 Jul 3.
3
An Evaluation of Curcumin-Encapsulated Chitosan Nanoparticles for Transdermal Delivery.姜黄素包封壳聚糖纳米粒经皮给药评价。
AAPS PharmSciTech. 2019 Jan 10;20(2):69. doi: 10.1208/s12249-018-1279-6.
4
Retinyl acetate-loaded nanoparticles: dermal penetration and release of the retinyl acetate.载视黄醇乙酸酯纳米粒:视黄醇乙酸酯的经皮渗透和释放。
Int J Pharm. 2011 Feb 14;404(1-2):281-8. doi: 10.1016/j.ijpharm.2010.11.019. Epub 2010 Nov 18.
5
Tracking the transdermal penetration pathways of optimized curcumin-loaded chitosan nanoparticles via confocal laser scanning microscopy.通过共聚焦激光扫描显微镜跟踪优化的载姜黄素壳聚糖纳米粒子的经皮渗透途径。
Int J Biol Macromol. 2018 Mar;108:753-764. doi: 10.1016/j.ijbiomac.2017.10.170. Epub 2017 Nov 7.
6
Biodegradable Ingredient-Based Emulgel Loaded with Ketoprofen Nanoparticles.载有酮洛芬纳米颗粒的可生物降解成分的乳凝胶。
AAPS PharmSciTech. 2018 May;19(4):1869-1881. doi: 10.1208/s12249-018-0997-0. Epub 2018 Apr 12.
7
Enhanced topical penetration, system exposure and anti-psoriasis activity of two particle-sized, curcumin-loaded PLGA nanoparticles in hydrogel.载姜黄素 PLGA 纳米粒水凝胶的两种粒径对提高透皮、系统暴露和抗银屑病活性的影响。
J Control Release. 2017 May 28;254:44-54. doi: 10.1016/j.jconrel.2017.03.385. Epub 2017 Mar 24.
8
Novel Chitosan Nanoparticles Loaded with Methotrexate for Topical Treatment of Psoriasis.载甲氨蝶呤的新型壳聚糖纳米粒子用于银屑病的局部治疗。
Pharm Nanotechnol. 2023;11(5):460-474. doi: 10.2174/2211738511666230502154110.
9
Lipid nanoparticles loading triptolide for transdermal delivery: mechanisms of penetration enhancement and transport properties.脂质纳米载体制剂透皮递送雷公藤红素:渗透增强机制和传输特性。
J Nanobiotechnology. 2018 Sep 15;16(1):68. doi: 10.1186/s12951-018-0389-3.
10
Evaluation of thermosensitive chitosan hydrogel containing gefitinib loaded cellulose acetate butyrate nanoparticles in a subcutaneous breast cancer model.载吉非替尼醋酸丁酸纤维素纳米粒的温敏壳聚糖水凝胶在皮下乳腺癌模型中的评价。
Int J Pharm. 2022 Aug 25;624:122036. doi: 10.1016/j.ijpharm.2022.122036. Epub 2022 Jul 19.

引用本文的文献

1
Exploring the synergistic effects of metformin and doxorubicin loaded chitosan nanoparticles for A549 lung cancer therapy.探索负载二甲双胍和阿霉素的壳聚糖纳米颗粒对A549肺癌治疗的协同作用。
Sci Rep. 2025 Jul 2;15(1):22657. doi: 10.1038/s41598-025-07996-2.
2
AG86 Peptide-modified Reactive Oxygen Species-responsive Polymer Nanovesicles for Transdermal Delivery of Hydrophilic Ergothioneine to Basal Keratinocytes.用于将亲水性麦角硫因经皮递送至基底角质形成细胞的AG86肽修饰的活性氧响应性聚合物纳米囊泡。
AAPS PharmSciTech. 2025 May 9;26(5):128. doi: 10.1208/s12249-025-03122-7.
3
Formulation and Evaluation of PLGA Nanoparticulate-Based Microneedle System for Potential Treatment of Neurological Diseases.
基于 PLGA 纳米粒的微针系统的配方与评价-用于治疗神经疾病的新策略。
Int J Nanomedicine. 2023 Jul 10;18:3745-3760. doi: 10.2147/IJN.S415728. eCollection 2023.